Get access

Infliximab-related malignant melanoma and cranial nerves IX and XII palsy secondary to IFN-α2b therapy

Authors

  • José M. Mir-Bonafé MD,

    1. From the Departments of Dermatology, Otolaryngology, and Oncology, University Hospital of Salamanca, Paseo de San Vicente, Salamanca, Spain
    Search for more papers by this author
  • Emilia Fernández-López MD,

    1. From the Departments of Dermatology, Otolaryngology, and Oncology, University Hospital of Salamanca, Paseo de San Vicente, Salamanca, Spain
    Search for more papers by this author
  • Javier Cañueto MD,

    1. From the Departments of Dermatology, Otolaryngology, and Oncology, University Hospital of Salamanca, Paseo de San Vicente, Salamanca, Spain
    Search for more papers by this author
  • María Gil-Melcón MD,

    1. From the Departments of Dermatology, Otolaryngology, and Oncology, University Hospital of Salamanca, Paseo de San Vicente, Salamanca, Spain
    Search for more papers by this author
  • Rocío García-Domínguez MD,

    1. From the Departments of Dermatology, Otolaryngology, and Oncology, University Hospital of Salamanca, Paseo de San Vicente, Salamanca, Spain
    Search for more papers by this author
  • Pablo de Unamuno-Pérez MD

    1. From the Departments of Dermatology, Otolaryngology, and Oncology, University Hospital of Salamanca, Paseo de San Vicente, Salamanca, Spain
    Search for more papers by this author

  • Conflicts of interest: The authors have no conflict of interest.

Dr José M. Mir-Bonafé, md
Department of Dermatology University Hospital of Salamanca
Paseo de San Vicente 58-182 37007
Salamanca Spain
E-mail: jmirbonafe@gmail.com

No abstract is available for this article.

Ancillary